VDS: Vitamin D Deficiency and Low Bone Mineral Content in Children
Study Details
Study Description
Brief Summary
The Vitamin D study is designed to investigate the effect of body fat mass on vitamin D levels in children. Earlier studies have shown that individuals with increased fat mass may have low vitamin D levels.
Our specific hypothesis states that children with increased fat mass will have lower blood levels of vitamin D when compared to non-obese children.Since vitamin D is the primary hormone for bone mineralization in humans, low levels of vitamin D could lead to decreased bone mineral content in these children.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Fifty prepubertal male and female children of ages between 3-12 years will participate in this study. Of these, 25 obese children will be enrolled in the study group, and 25 non-obese children will serve as controls.
All subjects will fill out a comprehensive mineral intake questionnaire as part of the study to ensure adequate calcium intake prior to the study.
All subjects will collect a first morning urine sample for calcium, creatinine, and NTX.
Fasting blood samples will be drawn for the following analytes: 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D, intact PTH, calcium, phosphorus, magnesium, osteocalcin, insulin, c-peptide, fasting blood glucose, leptin, and adiponectin.
Bone Mineral Content will be evaluated in 16 obese subjects with vitamin D level of < 30 nmol/L.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Obese Chilren with BMI of >95th percentile |
|
Non-obese Children with BMI of <85th percentile |
Outcome Measures
Primary Outcome Measures
- Bone mineral content [Baseline]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
General: Prepubertal children (males, with testicular volume of ≤ 3 cc, and girls with Tanner 1 breast) of ages 7-11 years will be enrolled in the study.
-
Study group: Subjects with a BMI of > 95th percentile for age and sex.
-
Control group: All control subjects will have a BMI of < 85th percentile for age and sex.
Exclusion Criteria:
-
known metabolic or genetic diseases resulting in obesity such as severe hypothyroidism, pseudohypoparathyroidism, or Cushing's disease
-
diabetes mellitus
-
subjects on lipid lowering medications
-
subjects on medications known to impact body weight or calcium homeostasis
-
subjects with a history of recent significant weight loss or gain
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Massachusetts Medical School | Worcester | Massachusetts | United States | 01655 |
Sponsors and Collaborators
- University of Massachusetts, Worcester
Investigators
- Principal Investigator: Benjamin U Nwosu, MD, University of Massachusetts, Worcester
- Study Director: Carol A Cicarrelli, RN, University of Massachusetts, Worcester
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H-12795